197 related articles for article (PubMed ID: 9072005)
1. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome.
Kumar-Singh S; Jacobs W; Dhaene K; Weyn B; Bogers J; Weyler J; Van Marck E
J Pathol; 1998 Nov; 186(3):300-5. PubMed ID: 10211120
[TBL] [Abstract][Full Text] [Related]
4. Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma.
Lindholm PM; Soini Y; Myllärniemi M; Knuutila S; Heikinheimo M; Kinnula VL; Salmenkivi K
J Clin Pathol; 2009 Apr; 62(4):339-44. PubMed ID: 19060016
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression.
Kumar-Singh S; Weyler J; Martin MJ; Vermeulen PB; Van Marck E
J Pathol; 1999 Sep; 189(1):72-8. PubMed ID: 10451491
[TBL] [Abstract][Full Text] [Related]
6. Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules.
Lee TC; Zhang Y; Aston C; Hintz R; Jagirdar J; Perle MA; Burt M; Rom WN
Cancer Res; 1993 Jun; 53(12):2858-64. PubMed ID: 7684950
[TBL] [Abstract][Full Text] [Related]
7. A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma.
Enomoto Y; Kasai T; Takeda M; Takano M; Morita K; Kadota E; Iizuka N; Maruyama H; Haratake J; Kojima Y; Ikeda N; Nonomura A
Pathol Int; 2012 Apr; 62(4):226-31. PubMed ID: 22449226
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor.
Menke AL; Shvarts A; Riteco N; van Ham RC; van der Eb AJ; Jochemsen AG
Cancer Res; 1997 Apr; 57(7):1353-63. PubMed ID: 9102224
[TBL] [Abstract][Full Text] [Related]
9. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
[TBL] [Abstract][Full Text] [Related]
11. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
Strizzi L; Catalano A; Vianale G; Orecchia S; Casalini A; Tassi G; Puntoni R; Mutti L; Procopio A
J Pathol; 2001 Apr; 193(4):468-75. PubMed ID: 11276005
[TBL] [Abstract][Full Text] [Related]
13. Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes.
Hoang CD; Zhang X; Scott PD; Guillaume TJ; Maddaus MA; Yee D; Kratzke RA
Cancer Res; 2004 Oct; 64(20):7479-85. PubMed ID: 15492273
[TBL] [Abstract][Full Text] [Related]
14. Identification of a tumor-specific methylation site in the Wilms tumor suppressor gene.
Kleymenova EV; Yuan X; LaBate ME; Walker CL
Oncogene; 1998 Feb; 16(6):713-20. PubMed ID: 9488035
[TBL] [Abstract][Full Text] [Related]
15. Analysis of WT1 target gene expression in stably transfected cell lines.
Thäte C; Englert C; Gessler M
Oncogene; 1998 Sep; 17(10):1287-94. PubMed ID: 9771972
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.
Rena O; Boldorini LR; Gaudino E; Casadio C
J Surg Oncol; 2011 Nov; 104(6):701-5. PubMed ID: 21437912
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
[TBL] [Abstract][Full Text] [Related]
18. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status.
Kobayashi M; Takeuchi T; Ohtsuki Y
Anticancer Res; 2008; 28(1A):197-208. PubMed ID: 18383846
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.
Filho AL; Baltazar F; Bedrossian C; Michael C; Schmitt FC
Diagn Cytopathol; 2007 Dec; 35(12):786-91. PubMed ID: 18008346
[TBL] [Abstract][Full Text] [Related]
20. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.
Park S; Schalling M; Bernard A; Maheswaran S; Shipley GC; Roberts D; Fletcher J; Shipman R; Rheinwald J; Demetri G
Nat Genet; 1993 Aug; 4(4):415-20. PubMed ID: 8401592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]